MoneyWorks4Me

The sales moved down -43.97% to Rs. 105.84 millions for the December 2024 quarter as compared to Rs. 188.91 millions during the corresponding quarter last year.A big decline of -66.40% was reported for the quarter ended December 2024 to Rs. 31.65  millions from Rs. 94.20 millions of corresponding previous quarter.A decline of 49.45 millions was observed in the OP in the quarter ended December 2024 from 101.06 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 105.84 188.91 -43.97 193.17 636.89 -69.67 745.73 588.34 26.75
Other Income 10.06 5.62 79.00 27.41 14.39 90.48 28.15 11.97 135.17
PBIDT 49.45 101.06 -51.07 81.52 164.09 -50.32 222.18 65.60 238.69
Interest 1.51 0.66 128.79 3.24 2.16 50.00 2.85 2.81 1.42
PBDT 47.94 100.40 -52.25 78.28 161.93 -51.66 219.33 62.79 249.31
Depreciation 6.98 5.12 36.33 20.60 15.33 34.38 20.50 18.38 11.53
PBT 40.96 95.28 -57.01 57.68 146.60 -60.65 198.83 44.41 347.71
TAX 9.31 1.08 762.04 15.78 1.09 1347.71 13.46 0.35 3745.71
Deferred Tax 0.42 0.04 950.00 1.35 0.03 4400.00 -0.16 0.27 -159.26
PAT 31.65 94.20 -66.40 41.90 145.51 -71.20 185.37 44.06 320.72
Equity 437.88 109.47 300.00 437.88 109.47 300.00 109.47 39.14 179.69
PBIDTM(%) 46.72 53.50 -12.66 42.20 25.76 63.80 29.79 11.15 167.21
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..